Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Real-World Data & Evidence CollectionPost-Market Safety Registries
Research, Drug Development & Manufacturing

MHRA Yellow Card

Also known as: Medicines and Healthcare products Regulatory Agency Yellow Card Scheme

UK safety reporting program for medicine and device adverse events. Psychedelic relevance: UK has active policy and trial activity, while public MHRA records indicate no authorized psilocybin medicinal product yet.

Real-World Data Snapshot

Verified

Verification

Verified

Coverage

1 country

Access Model

Open access

Last Verified

Apr 7, 2026

Methodology

Yellow Card accepts spontaneous adverse-event reports from professionals and the public and supports pharmacovigilance signal detection and regulatory follow-up.

Safety monitoring registriesWeeklySafety surveillance data

Primary Dataset

Access Yellow Card

Source Evidence

3 sources

MHRA Yellow Card Scheme

https://www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals

Yellow Card Portal

https://yellowcard.mhra.gov.uk/

MHRA FOI 23/101 (Psilocybin Context)

https://assets.publishing.service.gov.uk/media/65f0627fff1170001161598f/FOI_23-101_redacted.pdf

Quick Facts

Website
Visit